News - Pricing

Filter

Current filters:

Pricing

Popular Filters

650 to 674 of 675 results

German biotech calls for fair treatment of orphan drugs

17-06-2011

Orphan drugs are a rapidly expanding subsector of the pharmaceuticals industry. Martina Ochel, chief…

BiotechnologyEuropePricingRare diseasesRegulation

Pharma majors slash vaccine prices to poorest countries

07-06-2011

Several pharmaceutical majors, including the UK’s GlaxoSmithKline (LSE: GSK), US giants Merck &…

GardasilGlaxoSmithKlineGlobalJohnson & JohnsonMerck & CoPharmaceuticalPricingRotarixSanofiSanofi PasteurVaccines

EPHA calls for transparency of European medicines pricing

07-06-2011

In the framework of the European Commission consultation of the possible revision of the directive on…

EuropeGenericsPharmaceuticalPricing

UK OFT evaluation of Napp case finds increased competition in morphine market

07-06-2011

The UK’s Office of Fair Trading (OFT) has published an evaluation of its 2001 abuse of dominance…

EuropeGenericsMarkets & MarketingMorphineNapp PharmaceuticalsNeurologicalPricing

UNICEF decision to make vaccine prices public likely to have major impact on developing country markets

31-05-2011

In a bid to increase transparency and stimulate competition to bring down the prices of vaccines needed…

GlobalPharmaceuticalPricingVaccines

Patient access and industry competitiveness at stake in EU Transparency Directive review, says EFPIA

26-05-2011

With the review of the European Union’s Transparency Directive (Directive 89/105/EEC) gaining momentum,…

EuropeLegalPharmaceuticalPricingResearch

UK’s NICE recommends naftidrofuryl oxalate for symptoms of peripheral arterial disease

26-05-2011

The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending…

Cardio-vascularEuropeMerck SerononaftidrofurylPharmaceuticalPraxilenePricingRegulation

Drug reimbursement in the UK: What impact of value-based pricing?

25-05-2011

The UK's coalition government has embarked on a set of health care reforms designed to transform the…

EuropePharmaceuticalPricing

UK’s NICE backs Roche’s MabThera for first-line maintenance of follicular lymphoma

24-05-2011

The UK’s drug rationing watchdog the National Institute for Health and Clinical Excellence (NICE)…

EuropeMabTheraOncologyPharmaceuticalPricingRegulationRoche

USA’s HRSA issues first proposed regulation on 340B drug discount progam

24-05-2011

The USA’s Office of Pharmacy Affairs (OPA) of the Health Resources Services Administration (HRSA)…

North AmericaPharmaceuticalPricingRegulation

German biopharmaceuticals’ growth curbed by drug pricing reforms

23-05-2011

Demand for biopharmaceuticals continued to expand in Germany last year. Turnover in the genetically engineered…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPricingResearch

10% of US cancer patients abandoned oral drug therapy, often on cost grounds

20-05-2011

In the USA, 10% of cancer patients failed to fill their initial prescriptions for oral anti-cancer drugs,…

HealthcareNorth AmericaOncologyPharmaceuticalPricing

US cancer drug use and spending to rise sharply by 2013, followed by diabetes and CNS, says Medco

19-05-2011

Expensive new cancer drugs treating increasing numbers of patients could drive cancer drug spending by…

DiabetesMarkets & MarketingNeurologicalNorth AmericaOncologyPharmaceuticalPricing

Turkish pharma - pushed to the limit - calling off some investments

18-05-2011

Times are hard for pharmaceutical companies in Turkey, particularly research-based ones, who are left…

EuropeFinancialMarkets & MarketingPharmaceuticalPricing

US Medicare likely to run out of funds in 2024; Congressional Affordable Medicines Caucus

16-05-2011

The US Trustees of the Social Security and Medicare trust funds report on the current and projected financial…

GenericsHealthcareNorth AmericaPharmaceuticalPoliticsPricing

Despite boost to Australia mental health funding, latest schizophrenia drug still blocked

11-05-2011

As part of its latest budget announcement, Australia’s federal government has allocated A$2.2 billion…

HealthcareNeurologicalPharmaceuticalPoliticsPrevnarPricingVaccines

AstraZeneca achieves three significant milestones for blood thinner Brilique

10-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday announced three items of news regarding its…

AstraZenecaBrilintaBriliqueCardio-vascularEuropePharmaceuticalPricingRegulationResearch

Growth in Canadian drug spending slows to lowest rate since 1996

09-05-2011

Although drugs remain an important cost driver in Canada’s health system, growth in spending has…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

US Senators launch Bill to correct Medicare drug reimbursement

09-05-2011

A bipartisan bill, S 733, designed to address a Medicare reimbursement flaw and seeking to reverse cancer…

LegalOncologyPharmaceuticalPoliticsPricing

UK’s NICE says “no” to Novartis Tasigna and B-MS Sprycel, but better news on Afinitor

06-05-2011

The UK’s drug rationing body the National Institute for Health and Clinical Excellence (NICE) yesterday…

AfinitorBristol-Myers SquibbGlivecNovartisOncologyPharmaceuticalPricingRegulationSprycelTasigna

Australian government PBS decision lacks evidence base, trade group tells conference

06-05-2011

Australia’s federal government is ignoring its own growth forecasts for the Pharmaceutical Benefits…

Asia-PacificPharmaceuticalPoliticsPricing

Australian Health Minister will not reverse PBS drug listing decision

03-05-2011

Australia’s Federal Health Minister, Nicola Roxon has refused to back down from the government's…

Asia-PacificPharmaceuticalPoliticsPricing

Australian CPI rise in pharmaceuticals “due to PBS safety net”

28-04-2011

The apparent surge in pharmaceutical prices included in yesterday’s Australian Bureau of Statistics…

Asia-PacificPharmaceuticalPricing

650 to 674 of 675 results

Back to top